1-3 of 3
Jerome Zeldis, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide in Combination with Dexamethasone Was More Effective Than Dexamethasone in Patients Who Have Received Prior Thalidomide for Relapsed or Refractory Multiple Myeloma.

Michael Wang, MD, Robert Knight, MD, Melitios Dimopoulos, MD, David Siegel, MD, S. Vincent Rajkumar, MD, Thierry Facon, MD, Raymond Alexanian, MD, Zhinuan Yu, PhD, Jerome Zeldis, MD, PhD, Marta Olesnyckyj, Donna Weber, MD
Journal: Blood
Blood (2006) 108 (11): 3553.
https://doi.org/10.1182/blood.V108.11.3553.3553
Published: 2006
Journal Articles

Phase II Study of the Combination of Low-Dose Thalidomide, Prednisone, and Oral Cyclophosphamide (TPC Regimen) in the Treatment of Anemia, Splenomegaly, and Constitutional Symptoms Associated with Myelofibrosis with Myeloid Metaplasia (MMM).

Ruben A. Mesa, MD, Animesh Pardanani, MD, PhD, David P. Steensma, MD, Mark Litzow, MD, William Hogan, MD, Susan Geyer, PhD, Wenting Wu, PhD, Jerome Zeldis, MD, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2006) 108 (11): 2689.
https://doi.org/10.1182/blood.V108.11.2689.2689
Published: 2006
Journal Articles

Doxil (D), Vincristine (V), Reduced Frequency Dexamethasone (d) and Revlimid(R) (DVd-R) a Phase I/II Trial in Advanced Relapsed/Refractory Multiple Myeloma (RMM) Patients.

Mohamad A. Hussein, MD, Mary Ann Karam, RN, Catherine Brand, Greg L. Pearce, Janice Reed, RN, Kellie Bruening, Paul Sartori, Gordan Srkalovic, MD, PhD, Marta Olesnyckyj, RN, Robert Knight, MD, Kathe Balinski, RN, MA, Jerome Zeldis, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 208.
https://doi.org/10.1182/blood.V104.11.208.208
Published: 2004